Blinova, E.; Roshchin, D.; Kogan, E.; Samishina, E.; Demura, T.; Deryabina, O.; Suslova, I.; Blinov, D.; Zhdanov, P.; Osmanov, U.;
et al. Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment. Cells 2019, 8, 526.
https://doi.org/10.3390/cells8060526
AMA Style
Blinova E, Roshchin D, Kogan E, Samishina E, Demura T, Deryabina O, Suslova I, Blinov D, Zhdanov P, Osmanov U,
et al. Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment. Cells. 2019; 8(6):526.
https://doi.org/10.3390/cells8060526
Chicago/Turabian Style
Blinova, Ekaterina, Dmitry Roshchin, Evgenya Kogan, Elena Samishina, Tatiana Demura, Olga Deryabina, Irina Suslova, Dmitry Blinov, Pavel Zhdanov, Usif Osmanov,
and et al. 2019. "Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment" Cells 8, no. 6: 526.
https://doi.org/10.3390/cells8060526
APA Style
Blinova, E., Roshchin, D., Kogan, E., Samishina, E., Demura, T., Deryabina, O., Suslova, I., Blinov, D., Zhdanov, P., Osmanov, U., Nelipa, M., & Kaprin, A.
(2019). Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment. Cells, 8(6), 526.
https://doi.org/10.3390/cells8060526